Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.
D'Souza NC, Aiken JA, Hoffman EG, Atherley SC, Champsi S, Aleali N, Shakeri D, El-Zahed M, Akbarian N, Nejad-Mansouri M, Bavani PZ, Liggins RL, Chan O, Riddell MC.
D'Souza NC, et al. Among authors: akbarian n.
Front Pharmacol. 2024 Feb 28;15:1302015. doi: 10.3389/fphar.2024.1302015. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38510652
Free PMC article.